Positioning Early Phase CNS Trials for Investor Success

• Rethinking early phase strategy for pivotal trial success
• Expanding first-in-human to generate early proof-of-concept
• Smarter protocol design: upfront investment, timelines and downstream ROI

Speakers:

Peter Schmidt PhD

Chief Scientific Officer

Dr. Vince Clinical Research